US Stock Market Move | Q2 performance exceeds expectations, CAVA Group (CAVA.US) surged over 12% in early trading.
On Wednesday, CAVA Group (CAVA.US) surged over 12% in early trading, currently quoted at $68.27.
On Wednesday, CAVA Group (CAVA.US) surged over 12% in early trading, currently priced at $68.27. In terms of news, the companys Q2 2026 financial report exceeded market expectations. Q2 revenue reached $368.4 million, a year-on-year increase of 31.3%, surpassing Wall Street's forecast of $361 million; the adjusted earnings per share were $0.19, slightly higher than the market expectation of $0.18. The company reiterated its full-year guidance for fiscal year 2026, including a net opening of 75 to 77 new stores and a same-store sales growth target of 4.5% to 6.5%.
Jefferies assigned the company a "Buy" rating with a target price of $95, stating that CAVA remains one of the few growth stocks in the restaurant industry with investment value; RBC also raised its target price to $95 while maintaining an "Outperform" rating.
Related Articles

US Stock Market Move | The non-ferrous metal sector saw a widespread decline, with Century Aluminum Company (CENX.US) dropping over 5%.

The risks of AI ecosystem investment have been exaggerated by the market! Bank of America Corp supports NVIDIA Corporation (NVDA.US) with a target price of $350.

US Stock Market Move | Amylyx Pharmaceuticals (AMLX.US) surged nearly 51% as the Avexitide phase III LUCIDITY trial achieved its primary endpoint.
US Stock Market Move | The non-ferrous metal sector saw a widespread decline, with Century Aluminum Company (CENX.US) dropping over 5%.

The risks of AI ecosystem investment have been exaggerated by the market! Bank of America Corp supports NVIDIA Corporation (NVDA.US) with a target price of $350.

US Stock Market Move | Amylyx Pharmaceuticals (AMLX.US) surged nearly 51% as the Avexitide phase III LUCIDITY trial achieved its primary endpoint.

RECOMMEND





